Dr. Alali is an Assistant Professor in the Division of Pediatric Infectious Diseases and Global Health and serves as the Director of immunocompromised infectious disease service. His primary clinical and academic interests focus on acute and chronic infections in immunocompromised hosts including opportunistic fungal infections. Additionally, he is dedicated to medical education infectious disease transplant. His research focuses on understanding the impact of host-pathogen interactions and better understanding the infection risk in immunocompromised patients, including discovering new methods to quickly diagnose infection and evaluating the most appropriate treatment options specific to a pathogen. With cross knowledge between infectious disease and his oncology background, he is conducting multiple research projects to address some of the notable research gaps in pediatric febrile neutropenia (FN) management in children with cancer hematopoietic stem cell transplants (HSCT).